INTRODUCTION
The referral for dental general anaesthetic (DGA) is now deemed to be a treatment of 'last resort' 1 for children in advanced stages of dental disease who are too anxious, or too immature, to undergo dental treatment by other means. 2 The prospect of the DGA event has been found to provoke anxiety Background The project aims were to evaluate the benefi t of transmucosal midazolam 0.2 mg/kg pre-medication on anxiety, induction behaviour and psychological morbidity in children undergoing general anaesthesia (GA) extractions. Method One hundred and seventy-nine children aged 5-10 years (mean 6.53 years) participated in this randomised, double blind, placebo-controlled trial. Ninety children had midazolam placed in the buccal pouch. Dental anxiety was recorded preoperatively and 48 hours later using a child reported MCDAS-FIS scale. Behaviour at anaesthetic induction was recorded and psychological morbidity was scored by the parent using the Rutter Scale preoperatively and again one week later. Subsequent dental attendance was recorded at one, three and six months after GA. Results While levels of dental anxiety did not reduce overall, the most anxious patients demonstrated a reduction in anxiety after receiving midazolam premedication (p = 0.01). Neither induction behaviour nor psychological morbidity improved. Irrespective of group, parents reported less hyperactive (p = 0.002) and more pro-social behaviour (p = 0.002) after the procedure; older children improved most (p = 0.048). Post-GA dental attendance was poor and unaffected by premedication. Conclusion 0.2 mg/kg buccal midazolam provided some evidence for reducing anxiety in the most dentally anxious patients. However, induction behaviour, psychological morbidity and subsequent dental attendance were not found to alter.
with placebo. 10 This paper presents the data that evaluates the benefi t of 0.2 mg/ kg midazolam premedication on dental anxiety, anaesthetic induction distress, psychological morbidity and subsequent dental attendance.
AIMS
To evaluate the benefi t of midazolam 0.2 mg/kg deposited in the buccal pouch as a premedication upon child-reported dental anxiety, the observed behaviour of children at anaesthetic induction, postoperative psychological morbidity and continued dental attendance.
METHOD
A prospective, randomised, placebocontrolled, double blind clinical trial (registration number ISRCTN: 12026431; CTA 8000/13014) was conducted. Ethical approval was granted by the Area
• The fi rst double blind randomised controlled trial of transmucosal midazolam premedication in children undergoing a short ambulatory general anaesthesic (GA) for dental extractions.
• The fi ndings do not support the routine introduction of premedication of this dose of midazolam for children undergoing GA extraction.
Patients and recruitment
Children aged 5 to 10 years attending Glasgow Dental Hospital and School (GDH&S) for extractions were invited to participate after the need for DGA had been determined at a previous assessment visit. Following appropriate written consent, sampling was consecutive but limited by the capacity of the service and the availability of the research assistant (RA). Exclusion criteria included: patients who were not ASA I or II, those with learning disabilities, psychiatric disorder, non-fl uency in English, or where the family had no telephone for follow-up.
Recruitment took place between October 2004 and January 2006, during which time 2,495 children (aged 3-10 years) attended the service.
Randomisation and blinding
The randomisation occurred at the time of the DGA visit using an automated computerised system. The research nurse (RN) telephoned a dedicated line and obtained a treatment code for each subject. The general anaesthetic staff and the RA remained blind until the code was broken following the completion of data collection and input.
Premedication administration
The RN placed the medicine in the buccal sulcus using a needle-less syringe. The midazolam subjects each received 0.2 mg/ kg ('Epistat' preparation) while the placebo subjects received a similar volume prepared by the hospital pharmacy. The placebo premedication was designed to have a similar taste, texture and colour as the Epistat preparation. Children were encouraged to try not to swallow the medication but to allow mucosal absorption to occur. Approximately 30 minutes later, anaesthesia was induced by inhalation of sevofl urane, nitrous oxide and 40% oxygen and maintained with a similar mixture using a nasal mask or, occasionally though not routinely, a laryngeal mask. While asleep, an intravenous cannula was inserted into the child's hand. The children were monitored using ECG and pulse oximeter. Before the extractions, lignocaine with adrenaline infi ltrations were routinely injected into the buccal mucosa adjacent to the extraction site to reduce bleeding and to provide postoperative pain relief. The RN remained with the child throughout the procedure and until the child was fully recovered and assessed as fi t to discharge.
DATA COLLECTION
All data were collected by the RA.
Demographic
Demographic information was collected from the parent at the time of recruitment. This included the level of social deprivation -'DEPCAT' .
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Dental anxiety
Preoperative: dental anxiety was assessed before the administration of the premedicament, using the Modifi ed Child Dental Anxiety Scale (MCDAS) augmented by the Facial Image Scale (FIS). The MCDAS has eight dental anxiety items. The score in each question may vary from 1 (relaxed) to 5 (extremely worried), thus the total score may range from 5 to 40 and is well validated. 12, 13 In order to help the child confi rm their response on the MCDAS, they were asked to indicate which facial expression on the FIS also corresponded to their answer (facial expressions on the FIS range from smiling/relaxed through neutral to worried/sad).
Due to the young age of the present participants, however, it was inevitable that many of the children lacked experience of some of the dental procedures referred to in the MCDAS. Items for which the child had no experience were therefore omitted completely. Then, in order to render the scores comparable across children who answered different numbers of items, the average score was calculated for each child (that is, the sum of the scores for each of the individual answers, divided by the total number of answers). The resultant average scores (ranging from 0-5) Child's willingness to sit on dental chair Sits willingly on their own on dental chair Sits reluctantly on dental chair with some encouragement Sits on dental chair on parent's knee Parental physical restraint needed to hold patient on dental chair Child refuses to sit on dental chair 
Dental attendance
Dental appointments were arranged via the local community dental service clinic at one, three and six-months after discharge.
STATISTICAL ANALYSIS
Database preparation and analysis was conducted by the University of Glasgow Department of Statistics. The behaviour at induction was tabulated by group. The Rutter Scale data were analysed using the R statistics package. This included analysis of covariance, with linear models to examine the effects of further covariates. ANCOVA was also used to assess the MCDAS-FIS scores. Signifi cance was set at the 5% level. The original power calculation was based on the estimated effect of midazolam upon cognitive performance, and is reported elsewhere.
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RESULTS
One hundred and eighty-one subjects aged 5 to 10 years (mean 6.53 years) were recruited. Two patients were removed from the analysis when their study codes were found to have been reversed, leaving 179 subjects. The CONSORT fl ow chart (Fig. 1) shows patient recruitment and throughput. One subject from the placebo group was found to have contact dermatitis immediately following the DGA visit. This was unrelated to the premedication but she was withdrawn from postoperative follow-up. One subject did not receive a general anaesthetic following premedication. Table 2 , showing demographic and clinical patient information, confi rms that the midazolam and placebo groups were well matched.
Dental anxiety
One hundred and thirty-eight children (n = 71 midazolam) provided data preoperatively and 48 hours after GA. Means (and standard deviations and ranges) were as follows. Preoperative dental anxiety: midazolam: 2. An ANCOVA was conducted to explore the difference in dental anxiety between midazolam and placebo groups, with preoperative scores used as a co-variant. It was evident that many children had relatively low levels of preoperative anxiety which would not be reduced further by midazolam. Therefore, analysis was restricted to children scoring high in preoperative anxiety (MCDAS baseline score >2). These results demonstrated that midazolam premedication was then shown to be associated with a statistically signifi cant reduction in dental anxiety at 48 hours relative to placebo [estimated difference 0.31, standard error 0.12, p = 0.001].
were used to allow group comparisons.
It was also necessary to carry out a transformation of the MCDAS threshold scores for dental anxiety to equate them with the revised scoring procedure described above. The MCDAS norms classify scores of 8.8 as 'normal', scores of over 19 as 'anxious' and scores of over 31 as 'highly fearful' . 12, 13, 15 Transformation of these scores to a scale range of 0 to 5 results a score of 8.8 being equal to 1.1, a score of 19 being equal to 2.4, and a score of 31 being equal to 3.9.
The MCDAS-FIS was repeated, using the same method outlined above, 48 hours later at a home visit.
Observed behaviour at anaesthetic induction
Observed behaviour at induction was recorded using the 'Houpt' scale 16, 17 as shown in Table 1 , and was augmented with further criteria relating directly to the anaesthetic induction such as mask acceptance.
Pre-and postoperative emotional and behavioural assessment
The well validated and reliable Revised Rutter Scale for School-Age Children 
Observed behaviour at anaesthetic induction
One hundred and seventy-eight children provided data at anaesthetic induction. There was missing data for one child regarding mask acceptance; for another the general anaesthetic was cancelled following the premed for reasons unrelated to the study. When the results were tabulated (Table 1 ) and no observable differences were shown between the midazolam and placebo groups, no further statistical analysis was undertaken.
Pre-and postoperative emotional and behavioural assessment
Revised Rutter Scale for School Age Children: ANCOVA using age as a covariate was used. There were complete data for 153 participants (midazolam n = 81, placebo n = 72). Total Rutter score: a signifi cant effect (p = 0.048) was observed overall whereby children of 8 years of age and over showed a slight decrease in Rutter total score (that is, improvement) at one week compared to preoperative baseline score: midazolam (n = 13) change from baseline -2.3 (5.3); placebo (n = 12) change from baseline -1.7 (6.6). There were no signifi cant differences, however, as a function of premedication.
Emotional and conduct Rutter sub-scales scores: there were no signifi cant changes from baseline to one week in either the emotional or conduct behaviours (p = 0.071 and p = 0.214 respectively), and there was no effect of age.
Hyperactive Rutter sub-scale score: the midazolam and placebo groups both showed a signifi cant, though clinically small, decrease in hyperactivity from the preoperative to the one week assessments: midazolam p = 0.04, placebo p = 0.02, pooled data p = 0.002 [midazolam baseline 2.03 (1.74), one week 1.68 (1.85); placebo baseline 2.20 (1.61), one week 1.64 (1.84)]. However, there were no signifi cant differences between the treatment groups, nor was there a signifi cant effect of age.
Pro-social Rutter score: there was a significant improvement in pro-social behaviours from preoperative to week one assessments (p = 0.002) [midazolam baseline 15.5 (3.37), one week 16.51 (3.12); placebo baseline 14.76 (4.04), one week 15.69 (3.25)], but, again, there were neither signifi cant between-group differences nor any signifi cant effect of age. Table 3 shows the parents' stated intention that their child would attend the community dental service for one, three and sixmonth follow-up compared to their actual attendance at the clinic. No differences were observed between the groups.
Dental attendance
DISCUSSION
The present study shows that 0.2 mg/kg of transmucosal midazolam did not improve children's behaviour at anaesthetic induction or reduce postoperative morbidity. However, midazolam premedication was shown to reduce dental anxiety in the most dentally anxious children. While the difference was statistically signifi cant, it is unclear whether so small a change relative to placebo would have clinical signifi cance.
The low dose of midazolam may be the reason for these largely negative results, further exacerbated by the fact that some of the midazolam might have been swallowed rather than absorbed transmucosally. The dose of 0.2 mg/kg is lower than the normal oral dosage of 0.3 mg/kg up to 1.0 mg/kg. However, while a higher dose of midazolam might have exerted Missing data 0 1 Table 3 Children's attendance at the community dental service appointment and so this fi nding is important. However, collecting self-reported child anxiety data using with the MCDAS was a challenge in the present study. The subjects were young and found to have little prior knowledge of local analgesia and sedation, and so their comprehension of some parts of the MCDAS was poor. Therefore, it was necessary for us to compute new MCDAS threshold values denoting 'anxiety' . Data were thus converted into mean scores and similar cut-off points for dental anxiety were determined using previously published literature. 12, 13, 15 While sound methods were used to translate the scores, as this is not yet validated, even though it was derived in a logical way, our results should be interpreted with some caution.
For the sample as a whole, the behaviour of children appeared to improve after the DGA visit, with less hyperactivity and more positive engagement with their parents.
The reason for such a positive behaviour change is unclear and it must be borne in mind that these improvements were clinically small in that the magnitude of the improvement was less than 10%. The fact that postoperative emotional behaviour was better in the few children who were aged 8 years and above probably refl ects their more advanced developmental level, which confers greater understanding of the procedure and its effects with consequent benefi ts to their coping. This result is also consistent with evidence of a negative relationship between children's age and disturbed behaviour and non-cooperation 33, 34 and crying and restless behaviour after general anaesthesia. 35 One might also speculate that perhaps the children felt better now that their toothache was alleviated; an alternative proposal might be that the children were concerned that if they misbehaved they would be sent for repeat treatment. It could also be possible that children were relieved that the GA process was behind them.
It could be argued that screening to exclude non-anxious subjects should have been performed before administration of a premedicant. 36 However, the children in this sample were not undergoing ordinary elective surgical procedures; instead they had been referred for this radical treatment on account of their poor dental condition, toothache and likely pre-existing dental anxiety. 6, 37 The fact that the population in the present study had preoperative total Rutter scores approaching the previously validated indicator for clinically signifi cant 'disturbance' is evidence of their poor preoperative behavioural and emotional state. Despite parental agreement to continue to attend for dental follow-up, the results in this regard were disappointing, though not surprising given the previous dental history and social deprivation scores of the sample. It is possible that some parents preferred to attend their general dental practitioner. However, it is common for children to have lapsed registration following the DGA event.
Overall, this randomised placebo-controlled trial in children undergoing general anaesthesia for dental extractions has shown that 0.2 mg/kg midazolam placed in the buccal pouch did not benefi t dental anxiety generally; however, the most dentally anxious children experienced a reduction postoperatively. Behaviour at anaesthetic induction, postoperative psychological morbidity and subsequent dental attendance were not found to differ between the premedication groups. more benefi cial effects, 22 Ko et al. have shown 0.2 mg/kg to be effective in reducing emergence agitation and postoperative analgesic requirements. 23 Moreover, Erlandsson et al. have reported this dose to be effective for conscious sedation of uncooperative paediatric dental patients. 24 Nevertheless, Calipel et al. reported that even 0.5 mg/kg oral midazolam premedication was not an effective premedicant, even when compared to non-pharmacological approaches. 25 The authors had intended to administer a midazolam dose of 0.3 mg/kg but this was amended to 0.2 mg/kg on the insistence of the ethics committee, whose rationale was to reduce the risks of respiratory depression and disinhibited behaviour, given the very short interval between anaesthesia and discharge in this type of ambulatory service. As such, any benefi t to the child of a 0.3 mg/kg dose for this ultra-short procedure might have been outweighed by the known adverse cognitive side effects on discharge. 26 Interestingly, our cognitive function data confi rmed signifi cant shortterm impairment even at this low dose. 10 The subjects in the present study refl ect the type of child referred for dental extractions under general anaesthesia in Scotland in general and in this unit in particular. 27, 28, 30 Few recruits dropped out of the study and there was little missing data, and, surprisingly, only one child refused the premedfrom the placebo group. On refl ection, the results may have been infl uenced by the fact that both the RA and RN were in constant and emotionally supportive contact with the child and parent throughout. This might have been an unwitting confounding factor that is, nevertheless, well recognised in the literature. 29, 30 Thus, the supportive environment may in itself have achieved an effective level of preparation, 31, 32 to which the low dose of midazolam might have had little further to add. A 'placeboeffect' was clearly evident in that almost half of the control group was observed to be drowsy, disorientated or asleep before anaesthetic induction.
It is possible that the reduction in postoperative anxiety may be attributed to the amnesic effect of midazolam. A previous controlled study, on the same population though different recruits, confi rmed that children self-reported signifi cantly higher levels of dental anxiety postoperatively 6 
